Trey Martin in

Trey Martin

Login to view DISC.
President - Multiomics at Azenta Life Sciences
📍 United States

Trey Martin serves as the President of Multiomics at Azenta Life Sciences, bringing over 25 years of executive leadership in genomics and nucleic acid synthesis. His career includes roles as CEO of Maravai LifeSciences and SVP of Genomic Medicines at Danaher. He holds a bachelors degree in biochemistry from the University of Iowa.

He shows deep appreciation for scientific pioneers and mentorship, having publicly honored his late mentor, Dr. Joe Walder, as a "profound force." He also celebrates foundational scientific achievements, demonstrated by hosting Nobel laureate Dr. Katalin Karikó to discuss her work on mRNA medicines.

Unique fact: He hosted 2023 Nobel Prize winner Dr. Katalin Karikó to celebrate her foundational contributions to mRNA technology.

Read the full overview →
Experience
31 Years
Current Role
President - Multiomics
Location
United States
Personality Overview

How Trey shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Trey cares about

mRNA Technology
His expertise is centered on mRNA, having led companies pivotal to its application and hosted Nobel laureate Dr. Katalin Karikó to honor her work in the field.
Genomics Innovation
He has a distinguished career in genomics, having served as President of Integrated DNA Technologies and SVP of Genomic Medicines at Danaher Corporation.
+5 more topics Login to view topics
Career

Work history

4-2026
President - Multiomics
Azenta Life Sciences
7-2024 - 6-2025
Member - Board of Directors
Maravai LifeSciences
7-2023 - 6-2025
Chief Executive Officer
Maravai LifeSciences
12-2022 - 7-2023
President - Biologics Safety Testing
Maravai LifeSciences
7-2021 - 7-2022
Senior Vice President, Genomic Medicines
Danaher Corporation
In the press

Media appearances

Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution. Featured in Azenta Life Sciences (PRNewswire)
See now
Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution. Featured in PRNewswire
+2 more appearances Login to view media
Education
Biochemistry
University of Iowa
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Azenta Life Sciences Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Trey. Free, 10 seconds.